UTHEVER® NMN and the EU Novel Food Pathway: How EffePharm Builds Regulatory Confidence

Building Confidence Through Scientific Discipline

“Safety is reflected in the control of every detail and every parameter.”

For EffePharm, product development begins with a simple but demanding question: what do consumers and brand partners truly need from a science-based health ingredient? The answer is not limited to innovation. It also includes safety, traceability, regulatory readiness, and consistent manufacturing quality.

When UTHEVER® NMN made positive progress in the EU Novel Food process, EffePharm looked beyond the milestone itself. The company asked a more practical question: when customers choose UTHEVER®, what are they really choosing?

Part of the answer can be seen in technical details as small as 0.05 ppm.

For certain key impurity items, the required detection sensitivity in the submission process may need to reach 0.05 ppm. This does not mean every indicator follows the same threshold. Rather, it shows how carefully some safety-related parameters may need to be measured, documented, and controlled during a demanding regulatory review.

UTHEVER®’s EU Novel Food journey shows how EffePharm’s product philosophy works in practice. It is not only about one ingredient seeking access to one market. It is about how a science-based ingredient company builds a system that connects R&D, manufacturing, quality control, regulatory affairs, and global supply-chain coordination.

“All of our work ultimately points to the same goal: using scientific data and systematic capabilities to provide reliable, science-backed solutions for consumers’ health and wellness needs,” said Dr. Jianjun Yu, R&D Director at EffePharm.

For EffePharm, the long-term value of this journey goes beyond a single regulatory milestone. The company sees it as a way to build reusable capabilities for future ingredients, future markets, and future partners.

Engaging with Highly Regulated Markets

At the end of 2025, an Euromonitor report confirmed that EffePharm’s UTHEVER® NMN ingredient achieved a leading sales position in the North American market.*

At the same time, EffePharm had already started preparing for another important regulatory pathway: the European Union’s Novel Food framework. For a globally oriented ingredient company, engaging with major regulatory frameworks is not only about market expansion. It is also a way to strengthen internal systems and improve long-term execution.

The EU Novel Food process requires detailed safety assessment, strong documentation, and clear evidence around ingredient identity, production, purity, stability, intended use, and exposure. For EffePharm, this process tested every part of the company’s operating system, from R&D and manufacturing to quality control, regulatory affairs, and supply-chain coordination.

From the beginning, this was not treated as a single-point breakthrough. It was a coordinated project designed to align science, quality, compliance, and manufacturing under a more globally applicable framework.

Through this process, EffePharm aimed to establish a verifiable quality benchmark for itself and for its international partners.

When Process Becomes as Important as Technology

“Scientifically demonstrating the safety profile and intended use of an ingredient may follow a clear technical path. But having that evidence recognized under the EU Novel Food framework requires an entirely different level of documentation, logic, and regulatory discipline,” said Dr. Yu.

The difficulty of this process often lies not only in the science itself. The larger challenge is turning scientific data into a body of evidence that can be reviewed, questioned, and traced over time.

Dr. Yu explained that, in order to support the profile of a highly purified ingredient, the team needed to conduct long-term tracking, quantification, and method validation for potential impurities.

“Regulatory review is like an examination without a fixed end point,” he said. “Authorities do not only look at the final data. They also examine the entire problem-solving process, from R&D rationale and experimental design to testing reports. Any gap in logic or unclear area could affect the submission.”

The key requirement behind this process is traceability.

In practical terms, traceability means that every part of the process must be documented and retrievable: where raw materials come from, how each production step is performed, and how every figure in a testing report is generated. Even years later, the records should remain available for third-party review.

To support this requirement, EffePharm established an early-stage compliance review mechanism. In simple terms, quality and regulatory teams become involved early in R&D, reviewing project plans before development is completed. The goal is not to correct problems after the fact, but to design the project correctly from the beginning.

The quality team focuses on process stability and batch-to-batch consistency. The regulatory team evaluates the project against requirements from major regulatory frameworks. The purpose is not to slow innovation, but to help innovation move in the right direction from the start.

This process has influenced more than one project. It has reshaped how EffePharm manages product development internally. Even in markets with different regulatory requirements, the company continues to apply stricter internal logic around documentation, quality, and risk control.

Why Impurity Control Matters for NMN Ingredients

For NMN ingredients, impurity control is not only a laboratory issue. It is directly connected to product safety, regulatory confidence, and long-term brand trust.

In the control of certain key impurities, EffePharm’s internal standards may at times go beyond common industry practice or preliminary regulatory expectations. This is not about creating a technical barrier. It is a proactive approach to risk management.

“Setting a lower detection limit is like installing a more sensitive safety alarm,” said Jiayan Li, Head of Technical Regulatory Affairs. “It means we can identify and control potential risks while they are still at a very early and negligible stage, rather than waiting for an issue to emerge.”

This approach reflects a product philosophy built around the final user and the regulatory environment in which the ingredient will be used.

For EffePharm, R&D is not only about publishing papers or securing patents. It is about building an evidence system that can support responsible product use in major target markets. The standard for building this system is guided by consumer confidence, partner confidence, and long-term regulatory readiness.

Ultimately, this discipline becomes a risk buffer for brand partners.

“When our partners choose UTHEVER®, they are not only choosing an ingredient supported by scientific evidence,” said Xiaoran Gao, Head of Marketing. “They are also choosing a level of regulatory confidence. This helps reduce potential risks and uncertainties when brands launch new products, expand globally, or respond to sudden changes in regulatory policy.”

From a Compliance Project to Organizational Capability

The progress of UTHEVER® NMN in the EU is more than a regulatory milestone for EffePharm. It is also a process of turning a demanding project into long-term organizational capability.

Compliance is a bridge that companies must cross, but crossing the bridge is not the only goal. The deeper goal is to build a team that can work with complex regulatory expectations, develop repeatable methods, and turn compliance into a practical business capability.

This means the value of the project extends beyond a single ingredient.

If one only looks at NMN, authorization or market access may seem like the final goal. But when viewed through the lens of future growth, including more ingredients, broader markets, and long-term competition, the systems developed through this process become even more valuable.

Through the UTHEVER® project, EffePharm has strengthened several important capabilities:

• A cross-functional team with scientific, regulatory, and quality expertise
• A global collaboration network covering research institutions, CROs, and regulatory consultants
• A practical methodology spanning market insight, R&D, regulatory submission, and manufacturing

“The underlying logic of regulation in major global markets is connected,” said Dr. Yu. “The capabilities tested and refined during the EU review process can not only support UTHEVER® in entering more markets, but more importantly, they provide a proven framework and a higher-confidence starting point for the development and submission of EffePharm’s future ingredients.”

The deeper value of the UTHEVER® project is that it turns compliance from a required cost into a capability that can be reused, improved, and applied to future ingredients.

This marks an evolution in EffePharm’s role: from providing high-quality products to building and delivering systematic scientific, regulatory, and quality capabilities.

From NMN to a Broader Ingredient Portfolio

EffePharm’s mission remains clear: to provide science-based and reliable solutions in the dietary supplement field, starting from real health and wellness needs.

Its R&D strategy is grounded in human nutrition science. At present, the company focuses on areas including vitamins and minerals, specialty botanical extracts, enhancement technologies, and healthy aging ingredients.

As EffePharm expands into these areas, it is not starting from zero. The company is applying the R&D processes, compliance experience, and global collaboration network developed through the UTHEVER® NMN project to new ingredient development.

This is not only an extension of the product portfolio. It also represents a strategic evolution.

EffePharm is transforming the capabilities developed through major regulatory frameworks into a foundation that can support more innovation. In this sense, EffePharm’s role is evolving from an ingredient supplier into an ingredient innovator and science-based ingredient company capable of delivering systematic scientific, regulatory, and quality support.

Health needs are changing, and the product portfolio is expanding. But the foundation remains the same: a science-driven system built around reliability, quality, and regulatory confidence.

Q&A: What Supplement Brands Should Know

What should supplement brands look for in an NMN ingredient manufacturer?

Supplement brands should look beyond purity claims and price. A strong NMN ingredient manufacturer should provide clear identity documentation, impurity control, batch consistency, stability data, traceable manufacturing records, and regulatory support. For brands planning international expansion, experience with major regulatory frameworks is also valuable.

Why does impurity control matter for NMN ingredients?

Impurity control helps ensure that an NMN ingredient is consistently produced, properly characterized, and suitable for its intended use. For certain key impurity items, very sensitive detection methods may be required during regulatory review. Strong impurity control supports safety assessment, quality assurance, and long-term brand credibility.

Why is the EU Novel Food pathway important for NMN?

The EU Novel Food pathway requires a structured review of ingredient safety, identity, production, and intended use. For NMN, this pathway helps demonstrate whether the ingredient can be supported by a complete evidence package. For brands, it can provide a clearer signal of regulatory discipline and documentation strength.

How does regulatory readiness help brand partners?

Regulatory readiness can reduce uncertainty during product development, market entry, and international expansion. When an ingredient manufacturer has strong documentation and a clear compliance system, brand partners can build products with greater confidence and respond more effectively to changing market requirements.

Outlook: From Cost Advantage to Trust Advantage

The EU journey of UTHEVER® offers an important view into EffePharm’s broader strategic direction.

It shows how a globally oriented health technology company can use major regulatory frameworks to build long-term capabilities for the future. According to Dr. Yu, the deeper impact of this practice is that systematic compliance has become part of the company’s R&D logic and daily decision-making.

This is helping EffePharm move from simply making good products toward building a system that can be continuously reviewed, improved, and verified.

For EffePharm, this marks the beginning of a broader strategic stage. As an innovation-driven and science-based ingredient company, EffePharm is committed to turning the capabilities refined through the EU Novel Food process and EFSA-level expectations into a foundation that can support global health and wellness brands.

Future competition will increasingly depend on a company’s ability to deliver reliable, well-documented, and compliant solutions at scale.

In details as precise as 0.05 ppm, and through years of system building, EffePharm is turning regulatory discipline into a long-term guide for product development and corporate growth.

This is not only about the market access of one ingredient. It is about how EffePharm can build a more valuable role in the global health industry value chain: not only as a manufacturer, but as a science-based ingredient company that helps partners create safer, more reliable, and more competitive products.

*Source: Euromonitor International Consulting (Shanghai) Co., Ltd. Based on 2024 NMN ingredient sales volume in the U.S. market among registered trademark brands of NMN ingredients. Registered trademark brands of NMN ingredients refer to brands officially registered with government trademark authorities and clearly associated with NMN, or nicotinamide mononucleotide, an active ingredient that serves as a precursor to NAD+ and supports healthy aging. The research was completed in December 2025.

About EffePharm

EffePharm is a biotechnology company committed to delivering science-based functional health ingredients to consumers. The company continuously identifies market gaps and responds to evolving needs in life and health.

As a specialist in multiple single-ingredient categories, EffePharm has strong capabilities in product iteration, resource integration, and business innovation. Its work spans human nutrition, beauty and personal care, animal nutrition, and other fields.

EffePharm is dedicated to creating valuable brands for its customers and safe, effective, and sustainable products for consumers.